Cellulite Clinical Trial
Official title:
Sponsored Interventional Single-center Study for the Assessment of the Efficacy and Tolerability of a Medical Device in Crema-gel for the Treatment of PEF (Edemato-fibrosclerotic Panniculopathy of 2nd and 3rd Degree)
Post-marketing clinical study conducted on a CE medical device, named Defense Body, cellulite treatment, edematous fibrosclerotic panniculopathy (2nd and 3rd stage pathology), reducing draining cream-gel, to verify its effectiveness and tolerability on a panel of 56 subjects females affected by 2nd and 3rd degree PEF. The effectiveness of the device is measured in terms of reduction in thigh circumference, improvement in the appearance of the skin with reduction of the orange peel appearance and improvement in skin smoothness.
Post-marketing, sponsored, interventional, single-centre clinical study conducted on a medical device, already CE marked, named Defense Body cellulite treatment edematous fibrosclerotic panniculopathy (2nd and 3rd stage pathology) draining reducing gel-cream, to verify the its efficacy and tolerability on a panel of 56 female subjects, aged between 18 and 55, in good general health, and suffering from 2nd and 3rd degree PEF. A comparison study will be carried out between the clinical condition of the subjects at baseline T0, compared to the condition at the end of treatment T2, with provision for an intermediate visit halfway through treatment, T1. At the first enrollment visit (T0), the patient will be subjected to anthropometric measurements, measurement of the skin profile of the thigh, measurement of the thigh circumference and evaluation by the clinician of the degree of cellulite using pinch tests and digital photographs of the area. treated in profile and three-quarter view. After 4 (± 3 days) (T1) and 8 weeks (± 4 days) (T2) from the start of the study, the patient is visited again. The Doctor will repeat the assessments described at T0, with the addition of verifying continued compliance with the enrollment criteria; overall evaluation by the patient of satisfaction and compliance; recording of each AE or AED or drop-off; recording of any concomitant pharmacological treatment. The patient's overall assessment of satisfaction and compliance will be carried out only at the last visit. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03550157 -
Structural Changes of Subcutaneous Tissue by Ultrasonographies in Patients After Treatment With PnKCelulitis® Program
|
||
| Completed |
NCT03078647 -
Profound Dermal and SubQ Cartridges for the Treatment of Cellulite
|
N/A | |
| Suspended |
NCT05441917 -
Phototherapy and Radiofrecuency for Cellulite
|
N/A | |
| Completed |
NCT02942160 -
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
|
Phase 2 | |
| Active, not recruiting |
NCT02489994 -
Performance of the ePrime System for Cellulite
|
N/A | |
| Completed |
NCT01209767 -
Cryolipolysis and Subcision for Treatment of Cellulite
|
N/A | |
| Completed |
NCT01702259 -
Study of the Effect of Low Level Laser Light Therapy on Reducing the Appearance of Cellulite in the Thighs and Buttocks.
|
N/A | |
| Completed |
NCT04580303 -
CCH Treatment of Cellulite in the Presence of Dermal Laxity With Comparison Between Two (2) Different Injection Techniques
|
Phase 2 | |
| Completed |
NCT05358847 -
Treatment for Cellulite Appearance
|
N/A | |
| Terminated |
NCT04209530 -
Impact of CCH Treatment of Buttock and Thigh Cellulite in Adult Women
|
Phase 2 | |
| Completed |
NCT05064761 -
Safety and Effectiveness of Poly-l-lactic Acid (PLLA) for the Improvement in Appearance of Cellulite
|
N/A | |
| Completed |
NCT03329989 -
Safety and Effectiveness of EN3835 in the Treatment of EFP in Women
|
Phase 2 | |
| Completed |
NCT04170296 -
Real World CCH Study in Adult Females With Cellulite
|
Phase 3 | |
| Completed |
NCT04419454 -
Retrospective Evaluation of Cellulite of Laxity Treatment Using Body Tite
|
||
| Completed |
NCT05199506 -
Study to Evaluate the Safety and Effectiveness of the RAP Device for the Improvement in the Appearance of Cellulite
|
N/A | |
| Completed |
NCT05836779 -
A Study to Evaluate the Efficacy and Safety of CBL-514 in Participants With EFP; Cellulite (Stage 2)
|
Phase 2 | |
| Completed |
NCT05026216 -
To Assess the Effectiveness of Multiple Dose, Multiple Concentrations of Qwo, for the Treatment of Mild to Moderate Cellulite.
|
Phase 4 | |
| Completed |
NCT00399854 -
Evaluation of the Efficacy of Endermologie in Treatment of Cellulite and Body Contouring
|
Phase 4 | |
| Completed |
NCT00947414 -
Cellulite and Extracorporeal Shock Wave
|
N/A | |
| Completed |
NCT05419505 -
Study of Different Interventions to Reduce Bruising Following CCH-Aaes Treatment for Cellulite of the Buttocks
|
Phase 2 |